Page last updated: 2024-10-27

fluoxetine and Developmental Coordination Disorder

fluoxetine has been researched along with Developmental Coordination Disorder in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research Excerpts

ExcerptRelevanceReference
"Machado-Joseph Disease (MJD/SCA3) is an autosomal dominant spinocerebellar degeneration that evolves to disability and death."6.71Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study. ( Ferro, A; Jardim, LB; Monte, TL; Pereira, ML; Rieder, CR; Rockenback, I; Sequeiros, J; Silveira, I; Tort, AB, 2003)
"Machado-Joseph Disease (MJD/SCA3) is an autosomal dominant spinocerebellar degeneration that evolves to disability and death."2.71Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study. ( Ferro, A; Jardim, LB; Monte, TL; Pereira, ML; Rieder, CR; Rockenback, I; Sequeiros, J; Silveira, I; Tort, AB, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Monte, TL1
Rieder, CR1
Tort, AB1
Rockenback, I1
Pereira, ML1
Silveira, I1
Ferro, A1
Sequeiros, J1
Jardim, LB1

Trials

1 trial available for fluoxetine and Developmental Coordination Disorder

ArticleYear
Use of fluoxetine for treatment of Machado-Joseph disease: an open-label study.
    Acta neurologica Scandinavica, 2003, Volume: 107, Issue:3

    Topics: Adolescent; Adult; Cognition; Depression; Female; Fluoxetine; Humans; Machado-Joseph Disease; Male;

2003